C12N 2760/18362
By genetic engineering
Official title: by genetic engineering
C12N2760/18362 (By genetic engineering) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 8
- Inventors
- 28
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 3 |
By publication year.
Recent patents
- Methods and compositions for treating negative-sense single-stranded RNA virus18 Feb 2025US 12,227,769 B2Nationwide Children's Hospital, Inc.
- Paramyxovirus immunogens and related materials and methods21 Feb 2017US 9,572,876 B2Ohio State Innovation Foundation
- Recombinant human metapneumovirus and its use27 Apr 2010US 7,704,491 B2The United States of America as represented by the Department of Health and Human Services
- Methods and compositions for treating negative-sense single-stranded rna virus7 Aug 2025US 2025/0250548 A1Nationwide Children's Hospital, Inc.
- Vaccine composition against two respiratory viruses19 Jun 2025US 2025/0195637 A1
- Multivalent vaccine for paramyxoviruses and uses thereof22 May 2025US 2025/0161436 A1Icosavax, Inc.
- Methods and compositions for treating negative-sense single-stranded rna virus3 Feb 2022US 2022/0033783 A1Nationwide Children's Hospital, Inc.
- Paramyxovirus Immunogens and Related Materials and Methods23 Mar 2017US 2017/0080081 A1Ohio State Innovation Foundation
Most cited
By later US patents